TARGET (CT-FFR)
On-Site Computed Tomography-Derived Fractional Flow Reserve to Guide Management of Patients with Stable Coronary Artery Disease: the TARGET Randomized Trial
In 1,216 patients with stable coronary disease and an intermediate stenosis on CT angiography, an on-site machine-learning CT-FFR care pathway reduced invasive angiography without obstructive disease or intervention within 90 days compared with standard care.
The first RCT of on-site machine-learning CT-FFR as a care pathway: it met its primary endpoint by cutting non-actionable invasive angiograms, but revascularisation increased overall without any improvement in symptoms, quality of life or 1-year MACE — both results need saying together. Open-label, a process endpoint, and a cost trend (−4,233 yuan, P=0.07) that did not reach significance; whether the extra revascularisation helped or harmed is unanswered at one year.